AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹785 Cr | ₹792 Cr | ₹562 Cr | ₹576 Cr | ₹457 Cr |
What is the latest Cash Flow from Operating Activities ratio of AJANTA PHARMA ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹785 Cr |
Mar2023 | ₹792 Cr |
Mar2022 | ₹562 Cr |
Mar2021 | ₹576 Cr |
Mar2020 | ₹457 Cr |
How is Cash Flow from Operating Activities of AJANTA PHARMA Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹785 Cr | -0.89 | |
Mar2023 | ₹792 Cr | 41.02 | |
Mar2022 | ₹562 Cr | -2.53 | |
Mar2021 | ₹576 Cr | 26.17 | |
Mar2020 | ₹457 Cr | - |
Compare Cash Flow from Operating Activities of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹34,893.3 Cr | -4.2% | -2.5% | 44.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹435,407.0 Cr | 0.3% | 0.2% | 46% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,489.0 Cr | -2.7% | -0.1% | 58.9% | Stock Analytics | |
CIPLA | ₹117,443.0 Cr | -3% | -8.6% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,338.0 Cr | -0.1% | -3.4% | 7.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,244.9 Cr | 0.8% | 1.8% | 48.1% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | -4.2% |
-2.5% |
44.1% |
SENSEX | 0.7% |
2.5% |
17% |
You may also like the below Video Courses